4.27 USD
↗ 0.06 (1.43%)AT CLOSE (11:59 AM EDT)
Minerva Neurosciences, Inc
NERVNASDAQ • USD
4.27
↘ 0.01 (0.12%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
4.27
↘ 0.01 (0.12%)
Market: CLOSED
NERV is currently priced at $4.25. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (163.4%), a bullish Golden Cross on the moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Jul 17, 2026.
Open?$4.13
High?$4.41
Low?$4.01
Prev. Close?$4.21
Volume?169.9K
Avg. Volume?299.4K
VWAP?$4.23
Rel. Volume?0.57x
Bid / Ask
Bid?$3.69 × 100
Ask?$5.11 × 100
Spread?$1.42
Midpoint?$4.40
Valuation & Ratios
Market Cap?196.1M
Shares Out?46.6M
Float?39.1M
Float %?84.0%
P/E Ratio?N/A
P/B Ratio?-0.77
EPS?-$8.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
Employees
7
Market Cap
196.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-07-01
Address
1500 DISTRICT AVENUE
BURLINGTON, MA 01803
Phone: 617-600-7373
BURLINGTON, MA 01803
Phone: 617-600-7373
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.81Distress
Confidence?45%Low
Short InterestModerate
Short % of Float?4.87%Low
Short Interest?1.9M
Days to Cover?3.2
Free Float39.1M
Avg Daily Volume589.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?17.63Strong
Quick Ratio?17.63Strong
Cash Ratio?7.29Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-0.77CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?163.4%STRONG▾
Peers50
S&P97
ROA?-441.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$163.5M
Fundamentals ratios updated end of day